Apiam Animal Health Limited (ASX: AHX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Apiam Animal Health Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Apiam Animal Health Limited (ASX: AHX)
Latest News

a woman
Cheap Shares

3 shares to buy next week

These 3 shares are at their lowest value for a long time.

Read more »

a woman
⏸️ Investing

Who else wants to diversify their portfolio?

These businesses could diversify your portfolio nicely.

Read more »

a woman
⏸️ Investing

ALL ORDINARIES finishes lower Monday: 8 shares you missed

The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished lower on Monday.

Read more »

a woman
⏸️ Investing

3 small cap dividend shares

These 3 dividend shares all have growth and dividend potential.

Read more »

a woman
⏸️ Investing

Who else wants to diversify their portfolio?

These 3 shares would be good options for diversification.

Read more »

a woman
⏸️ Investing

3 small caps with big potential

These 3 small caps could create exciting returns.

Read more »

a woman
⏸️ Investing

Buy these 3 stocks to instantly diversify your portfolio

I think these 3 shares would add good diversification to any portfolio.

Read more »

a woman
⏸️ Investing

2 earnings results you might have missed on Friday

The Regis Healthcare Ltd (ASX:REG) share price and the Apiam Animal Health Ltd (ASX:AHX) share price were on the move…

Read more »

a woman
⏸️ Investing

Why these 4 ASX shares have started the week deep in the red

The Domino's Pizza Enterprises Ltd. (ASX:DMP) share price is one of four starting the week deep in the red. Here’s…

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
12 Feb 2026 $0.1000 100.00% Special Cash 16 Feb 2026
02 Sep 2025 $0.0100 100.00% Final 25 Sep 2025
03 Mar 2025 $0.0100 100.00% Interim 28 Mar 2025
28 Aug 2024 $0.0100 100.00% Final 30 Sep 2024
04 Mar 2024 $0.0100 100.00% Interim 03 Apr 2024
21 Sep 2022 $0.0040 100.00% Final 21 Oct 2022
21 Mar 2022 $0.0120 100.00% Interim 20 Apr 2022
16 Sep 2021 $0.0120 100.00% Final 22 Oct 2021
19 Mar 2021 $0.0120 100.00% Interim 23 Apr 2021
17 Sep 2020 $0.0120 100.00% Final 23 Oct 2020
20 Mar 2020 $0.0080 100.00% Interim 24 Apr 2020
19 Sep 2019 $0.0080 100.00% Final 24 Oct 2019
19 Mar 2019 $0.0080 100.00% Interim 24 Apr 2019
19 Sep 2018 $0.0080 100.00% Final 26 Oct 2018
13 Mar 2018 $0.0080 100.00% Interim 27 Apr 2018
20 Sep 2017 $0.0000 100.00% Final 27 Oct 2017
13 Mar 2017 $0.0080 100.00% Interim 27 Apr 2017

AHX ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
23 Feb 2026 Andrew Vizard Sell 363,284 $317,873
As advised by the company. Acquisition of Apiam Animal Health Limited by Pepper Bidco Pty Ltd by way of scheme of arrangement.
23 Feb 2026 Bruce Dixon Sell 10,920,078 $9,555,068
As advised by the company. Acquisition of Apiam Animal Health Limited by Pepper Bidco Pty Ltd by way of scheme of arrangement.
23 Feb 2026 Vita Pepe Sell 13,074,123 $11,439,857
As advised by the company. Acquisition of Apiam Animal Health Limited by Pepper Bidco Pty Ltd by way of scheme of arrangement.
23 Feb 2026 Richard (Rick) Dennis Sell 13,038 $11,408
As advised by the company. Acquisition of Apiam Animal Health Limited by Pepper Bidco Pty Ltd by way of scheme of arrangement.
20 Jun 2025 Vita Pepe Buy 105,957 $46,589
On-market trade.
19 Jun 2025 Vita Pepe Buy 75,625 $33,237
On-market trade.
16 Jun 2025 Vita Pepe Buy 68,238 $27,158
On-market trade.
28 Mar 2025 Andrew Vizard Buy 9,966 $3,532
Dividend Reinvestment Plan (DRP).
28 Mar 2025 Richard (Rick) Dennis Buy 357 $126
Dividend Reinvestment Plan (DRP).
28 Mar 2025 Christopher Richards Buy 165,032 $64,989
On-market trade.
28 Mar 2025 Christopher Richards Buy 1,220,698 $432,737
Dividend Reinvestment Plan (DRP).
24 Mar 2025 Christopher Richards Buy 112,406 $40,735
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Professor Andrew Lancelot Vizard Non-Executive ChairmanNon-Executive Director Nov 2015
Professor Vizard is a Principal Fellow at the Faculty of Veterinary and Agricultural Sciences, University of Melbourne and previously Associate Professor of Veterinary Epidemiology and Director of The Mackinnon Project, a recognised leader in sheep and beef veterinary consultancy. An experienced company director, he has previously held directorships in ASX companies, statutory bodies and research organisations including Animal Health Australia, the body responsible for coordinating Australias animal health system; Primesafe, the statutory authority responsible for regulating the production of safe meat in Victoria; and the Australian Wool Corporation. He is currently Chair of the Vizard Foundation and Executive Secretary for the Hermon Slade Foundation and the Australia & Pacific Science Foundation.
Mr Bruce Robert Dixon Non-Executive Director Oct 2024
Mr Dixon has over 30 years of management, commercial and Board experience including as Nonexecutive Director of Greencross Limited and Ruralco Limited. He was also the cofounder and Chair of Australian Venue Co (AVC), where following its sale to KKR in 2017, he remained on the AVC Board and as a shareholder until its sale in early 2024. He also previously held the position of Chief Executive Officer of Spotless Group Holdings Ltd and Healthscope Limited and Executive Director of Linen Services Australia and is a director of a number of private companies.
Ms Vita Pepe Non-Executive Director Jun 2025
Ms Pepe has over 25 years of executive and board level experience across the healthcare, hospitality and services sectors. She has held the role of Chief Operating Officer at Healthscope Limited and Spotless Group. She was also a cofounder and Board Director of Australian Venue Company (AVC). She has also served as CEO within the public health sector and brings deep experience in hospital management and community health services. She was Executive Chairman of Linen Services Australia.
Mr Richard (Rick) John Dennis Non-Executive Director Nov 2015
Mr Dennis held several senior roles for over 35 years with Ernst & Young (EY) and was the Managing Partner of EYs Queensland practice on two occasions from 2001-2007 and from 2014-15. He also held several executive management roles at EY, including Deputy COO and CFO for the Asia Pacific practice where he was responsible for overseeing the financial and operational integration of EYs Australian and Asian member firms. He is nonexecutive Chair of AF Legal Group Limited, Motorcycle Holdings Limited, Energy Resources of Australia Limited, and a nonexecutive director of Cettire Limited and Step One Clothing Limited. He is also an external member of the Audit & Risk Committee of Racing Qld.
Ms Evonne Maree Collier Non-Executive Director Oct 2022
Ms Collier has served as a Chair and Nonexecutive Director on various boards since 2011 and currently serves as Chair of Curae Health. her executive career was with blue chip, multinational companies in Csuite Strategy, Sales/Marketing and R&D/Innovation positions, specialising in business turnarounds and digital and eCommerce products, channels and transformation.
Ms Natalie Sylvia Climo Company Secretary Nov 2025
-
Matthew White Chief Financial Officer
-
Renee Waters Chief People Officer
-
Duncan Runciman Chief Veterinary Officer
-
Natalie Sylvia Climo Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
CJOEA Family Company Pty Ltd <Richards Family A/C> 38,472,133 20.92%
Petstock Investments Pty Ltd 21,240,500 11.55%
Pepe Corporation Pty Ltd <Vita Pepe Super Fund A/C> 12,511,197 6.80%
Netwealth Investments Limited <Wrap Services A/C> 10,997,451 5.98%
HSBC Custody Nominees (Australia) Limited 3,348,301 1.82%
3FJ Pty Ltd <Fojo Super Fund A/C> 3,206,915 1.74%
CJOEA Family Company Pty Ltd <Richards Family A/C> 1 2,786,961 1.52%
Mr Brian Scutt 2,728,822 1.48%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 2,467,115 1.34%
Cobash Pty Limited <J & S Wright Family A/C> 1,872,006 1.02%
Equitave Pty Ltd <Theo Family A/C> 1,813,000 0.99%
Orem Holdings Pty Ltd 1,751,769 0.95%
Mr Roger Charles Carmody & Mrs Maris Moore Carmody <Sandridge S/F A/C> 1,742,791 0.95%
Jinland Pty Ltd <Jinland Family A/C> 1,710,000 0.93%
Hamilton Animal Health Pty Ltd 1,564,270 0.85%
Fergus Macbeth Hay 1,446,946 0.79%
BVS Super Co Pty Ltd <Bvs Superannuation Fund A/C> 1,407,813 0.77%
Mast Financial Pty Ltd <A To Z Investment A/C> 1,400,000 0.76%
Velkov Funds Management Pty Ltd <Victor Value Fund A/C> 1,400,000 0.76%
Four Post Investments Pty Ltd <Johnstone Investment A/C> 1,386,700 0.74%

Profile

since

Note